Bajaj Healthcare Reports Nil Deviation in Preferential Issue Proceeds Utilization
Bajaj Healthcare Ltd · Others (Uncategorized) · 17 Oct 2026, 11:27 pm
Bajaj Healthcare Reports Nil Deviation in Preferential Issue Proceeds Utilization Bajaj Healthcare confirmed nil deviation or variation in the utilization of funds raised via equity shares allotted on conversion of warrants for the quarter ended 30th Sep'26. Against a modified total allocation of ₹20,497.00 Lakhs, the company has deployed ₹19,905.96 Lakhs. Key deployments include ₹15,000.00 Lakhs fully utilized toward secured/unsecured loan repayments, ₹2,912.48 Lakhs utilized out of ₹3,500.00 Lakhs allocated for capital expenditure, and ₹1,993.48 Lakhs utilized for general corporate purposes. CARE Ratings continues as the monitoring agency.
Original exchange filing (PDF)
More announcements from Bajaj Healthcare Ltd
- Transcript of Earnings Call for Q2H1FY27 · 27 Oct 2026
- Intimation for Audio Recording of Earnings Call for Q2FY27 · 20 Oct 2026
- Press Release on the financial results of the Company for the quarter ended September 30, 2026 · 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 · 17 Oct 2026
- Financial Results for the quarter ended September 30, 2026 · 17 Oct 2026
- Bajaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 17 Oct 2026
- Outcome of the Board Meeting held on 17th October 2026 · 17 Oct 2026
- Receipt of Hon''ble NCLT Order approving acquisition of Genrx Pharmaceuticals Private Limited on a going concern basis · 14 Oct 2026
